P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL

Catalog number BNC400103-500

Price for BNC400103-500

Size / count 1x 500 µL

About this product

Epstein-Barr virus (EBV), also designated human herpesvirus 4 (HHV-4), is a member of the herpesvirus family and is one of the most common human viruses. EBV infects B cells and, though often asymptomatic, it can cause infectious mononucleosis, a disease characterized by fatigue, fever, sore throat and muscle soreness. The EBV-induced early antigens (Ea) are among several antigen complexes that have been identified in EBV-infected cells. The Ea complex is composed of diffuse (Ea-D) and restricted (Ea-R) components. The activity of Ea-D is suppressed during latent infection. BMRF1, the gene that encodes for Ea-D, is closely associated with the gene encoding for EBV DNA polymerase, and Ea-D is essential for the activity of this polymerase. Ea-D forms a complex with EBV DNase and, together, they may play a role in viral replication. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC400103-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: EBNA1; EBV nuclear antigen 1; Epstein Barr nuclear antigen 1; Human Herpesvirus 4 (HHV4)
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
UniProt: Not Applicable
Swiss Prot: Not Applicable
Host: Mouse
Species Reactivity: EBV
Reactivity: P55;50 EBV Early Antigen
Target Antigen: p55;50 EBV Early Antigen
Clonality: Monoclonal
Clone: 1108-1
Type: Primary
Source: Animal
Origin: Animal
Applications: IF (published) |IP (published) |WB (published)
Field of Research: Infectious disease, Virology
Positive Control: EBV-infected cells or tissues
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 50/55 kDa doublet
References & Citations: Note: References for this clone sold by other suppliers may be listed for expected applications. J Virol (1984) 50(2): 372-379. (IP, WB, IF) PLoS ONE 7(11): e48788. (IHC, FFPE)
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF640R

Frequently Asked Questions

What is the catalog number for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL?

The catalog number for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL is BNC400103-500.

What sizes are available for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL?

P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.

Is P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL in stock?

P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL?

P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL?

Estimated delivery time for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL?

The safety data sheet for P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0298061270361e100db0/msds/bnc400103-500.pdf.

What is P55;50 EBV-Early Antigen (1108-1), CF640R conjugate, 0.1mg/mL used for?

Is this product tested for endotoxin levels?

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Can I request additional validation data, such as western blot images, for this product?

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.